EntrepreneurialCheck

C16 Biosciences valuation

The estimated C16 Biosciences valuation is $200.0M. This C16 Biosciences valuation is an independent model output, not a verified appraisal, official mark, or financial advice. Founders: David Heller net worth, Harry McNamara net worth, and Shara Ticku net worth.

David Heller
Founder
$14.0M
Harry McNamara
Founder
$14.0M
Shara Ticku
CEO
$28.0M

Search this company in the directory

FAQ: C16 Biosciences valuation and founders net worth

What is C16 Biosciences's valuation?

The estimated C16 Biosciences valuation is $200.0M. This C16 Biosciences valuation is an independent model output, not a verified appraisal, official mark, or financial advice.

How much did C16 Biosciences raise?

C16 Biosciences raised $20.0M in disclosed funding. How much C16 Biosciences raised informs the estimated C16 Biosciences valuation on this hub. Independent estimate only — not a complete financing history or financial advice.

Who founded C16 Biosciences?

David Heller, Harry McNamara, and Shara Ticku founded C16 Biosciences. Estimated net worth for each founder is on the linked profile. Figures are independent model estimates, not verified net worth.